Necuparanib is under investigation in clinical trial NCT01621243 (M402 in Combination With Nab-paclitaxel and Gemcitabine in Pancreatic Cancer).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.